Stage 0 in GOLD does not predict future clinical COPD

J. Vestbo, P. Lange (Hvidovre, Denmark)

Source: Annual Congress 2002 - Longitudinal studies of COPD
Session: Longitudinal studies of COPD
Session type: Oral Presentation
Number: 2548
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vestbo, P. Lange (Hvidovre, Denmark). Stage 0 in GOLD does not predict future clinical COPD. Eur Respir J 2002; 20: Suppl. 38, 2548

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
GOLD stage 0 and risk of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003

Prediction of the clinical course of COPD using the old and the new GOLD classification
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II
Source: Eur Respir J 2005; 26: Suppl. 49, 434s
Year: 2005

COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002

Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003

The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005

Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


The distribution of COPD in general practice using three different GOLD classification
Source: International Congress 2018 – COPD around the world
Year: 2018


Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011


Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018